No abstract available
Keywords:
Business; Public health; SARS-CoV-2; Vaccines.
MeSH terms
-
COVID-19 Vaccines
-
Clinical Trials, Phase III as Topic
-
Confidentiality
-
Coronavirus Infections / economics
-
Coronavirus Infections / prevention & control
-
Developed Countries / economics*
-
Developed Countries / statistics & numerical data*
-
Drug Approval
-
Drug Costs / ethics
-
Drug Industry / economics
-
Drug Industry / ethics
-
Global Health / ethics*
-
Global Health / statistics & numerical data
-
Healthcare Disparities / ethics*
-
Healthcare Disparities / statistics & numerical data*
-
Hoarding / economics
-
Humans
-
Influenza A Virus, H1N1 Subtype / immunology
-
International Cooperation
-
Needs Assessment / ethics
-
Time Factors
-
Viral Vaccines / biosynthesis
-
Viral Vaccines / chemical synthesis
-
Viral Vaccines / economics*
-
Viral Vaccines / supply & distribution*
Substances
-
COVID-19 Vaccines
-
Viral Vaccines